These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35162872)

  • 1. Predicting Self-Medication with Cannabis in Young Adults with Hazardous Cannabis Use.
    Wallis D; Coatsworth JD; Mennis J; Riggs NR; Zaharakis N; Russell MA; Brown AR; Rayburn S; Radford A; Hale C; Mason MJ
    Int J Environ Res Public Health; 2022 Feb; 19(3):. PubMed ID: 35162872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults.
    Leadbeater BJ; Ames ME; Linden-Carmichael AN
    Addiction; 2019 Feb; 114(2):278-293. PubMed ID: 30276906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis use moderates the relationship between pain and negative affect in adults with opioid use disorder.
    Wilson M; Gogulski HY; Cuttler C; Bigand TL; Oluwoye O; Barbosa-Leiker C; Roberts MA
    Addict Behav; 2018 Feb; 77():225-231. PubMed ID: 29078148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Withdrawal, Mood, and Sleep Inventories After Monitored 3-Week Abstinence in Cannabis-Using Adolescents and Young Adults.
    Sullivan RM; Wallace AL; Stinson EA; Montoto KV; Kaiver CM; Wade NE; Lisdahl KM
    Cannabis Cannabinoid Res; 2022 Oct; 7(5):690-699. PubMed ID: 34678051
    [No Abstract]   [Full Text] [Related]  

  • 5. Attention deficit hyperactivity disorder, other mental health problems, substance use, and driving: examination of a population-based, representative canadian sample.
    Vingilis E; Mann RE; Erickson P; Toplak M; Kolla NJ; Seeley J; Jain U
    Traffic Inj Prev; 2014; 15 Suppl 1():S1-9. PubMed ID: 25307372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relations between anxious, depressive and borderline symptomatology and frequency of cannabis use and dependence].
    Chabrol H; Duconge E; Roura C; Casas C
    Encephale; 2004; 30(2):141-6. PubMed ID: 15107716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State medical marijuana laws, cannabis use and cannabis use disorder among adults with elevated psychological distress.
    McBain RK; Wong EC; Breslau J; Shearer AL; Cefalu MS; Roth E; Burnam MA; Collins RL
    Drug Alcohol Depend; 2020 Oct; 215():108191. PubMed ID: 32736294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults.
    Livne O; Shmulewitz D; Lev-Ran S; Hasin DS
    Drug Alcohol Depend; 2019 Feb; 195():170-177. PubMed ID: 30361043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-domain correlates of cannabis use disorder severity among young adults.
    Schuster RM; Hareli M; Moser AD; Lowman K; Gilman J; Ulysse C; Schoenfeld D; Evins AE
    Addict Behav; 2019 Jun; 93():212-218. PubMed ID: 30753972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis withdrawal in the United States: results from NESARC.
    Hasin DS; Keyes KM; Alderson D; Wang S; Aharonovich E; Grant BF
    J Clin Psychiatry; 2008 Sep; 69(9):1354-63. PubMed ID: 19012815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with the timing and onset of cannabis use and cannabis use disorder: results from the 2007 Australian National Survey of Mental Health and Well-Being.
    Butterworth P; Slade T; Degenhardt L
    Drug Alcohol Rev; 2014 Sep; 33(5):555-64. PubMed ID: 25186194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between cannabis use and anxiety disorders: Results from a population-based representative sample.
    Feingold D; Weiser M; Rehm J; Lev-Ran S
    Eur Neuropsychopharmacol; 2016 Mar; 26(3):493-505. PubMed ID: 26775742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms.
    Russo EB; Cuttler C; Cooper ZD; Stueber A; Whiteley VL; Sexton M
    Cannabis Cannabinoid Res; 2022 Oct; 7(5):706-716. PubMed ID: 34569849
    [No Abstract]   [Full Text] [Related]  

  • 14. [Substance use, affective problems and personality traits: test of two association models].
    Chakroun N; Doron J; Swendsen J
    Encephale; 2004; 30(6):564-9. PubMed ID: 15738859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis use disorder trajectories and their prospective predictors in a large population-based sample of young Swiss men.
    Marmet S; Studer J; Wicki M; Gmel G
    Addiction; 2021 Mar; 116(3):560-570. PubMed ID: 32621560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis use in civilian college students and college student service members/veterans: the moderating effect of anxiety.
    Teeters JB; Woodward MJ; Meshesha LZ; Tripp JC
    Am J Drug Alcohol Abuse; 2020 Nov; 46(6):777-783. PubMed ID: 32469609
    [No Abstract]   [Full Text] [Related]  

  • 17. [Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls].
    Dorard G; Bungener C; Phan O; Edel Y; Corcos M; Berthoz S
    Encephale; 2018 Feb; 44(1):2-8. PubMed ID: 27637871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between cannabis use disorders and social anxiety disorder in the National Epidemiological Study of Alcohol and Related Conditions (NESARC).
    Buckner JD; Heimberg RG; Schneier FR; Liu SM; Wang S; Blanco C
    Drug Alcohol Depend; 2012 Jul; 124(1-2):128-34. PubMed ID: 22266089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety and cannabis-related problem severity among dually diagnosed outpatients: The impact of false safety behaviors.
    Buckner JD; Zvolensky MJ; Ecker AH; Jeffries ER; Lemke AW; Dean KE; Businelle MS; Gallagher MW
    Addict Behav; 2017 Jul; 70():49-53. PubMed ID: 28214433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-medication of mood and anxiety disorders with marijuana: Higher in states with medical marijuana laws.
    Sarvet AL; Wall MM; Keyes KM; Olfson M; Cerdá M; Hasin DS
    Drug Alcohol Depend; 2018 May; 186():10-15. PubMed ID: 29525698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.